Last update:

Immunology news

Oncology & Cancer

Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors

In the fight against cancer, chimeric antigen receptor T cell (CAR-T) therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors.

Oncology & Cancer

Epigenetic test could help predict efficacy of immunotherapy in multiple myeloma

Multiple myeloma is a type of blood cancer that appears mainly after the age of 60. Its incidence, therefore, increases with the aging of the population. In this pathology, the bone marrow, the porous structure within the ...

Immunology

Gut bacteria engineered to act as tumor GPS for immunotherapies

Immunotherapeutic approaches have substantially improved the treatment of patients with advanced malignancies. However, most advanced and metastatic malignancies remain incurable and therefore represent a major unmet need.

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Psychology & Psychiatry

Research reveals gene expression's role in depression and immunity

A new study, conducted in a shared effort between U.K. and Italian researchers offers novel insights about the biological mechanisms behind major depressive disorder (MDD), and especially on the role of the immune system.

Diseases, Conditions, Syndromes

Biomarker can help health care assess severity of COVID-19

Researchers at Karolinska Institutet and the University of Gothenburg have identified a biomarker that could become an important tool for health care in assessing patients with acute COVID-19 infection. The researchers have ...

Diseases, Conditions, Syndromes

Understanding liver fibrosis: Insights from Alagille syndrome

What influences the extent of scar tissue, or fibrosis, that develops in the liver when people suffer from liver disease? While a small amount of fibrosis is a normal part of the healing process, excessive fibrosis can occur, ...

Immunology

Here's why B cells benefit from booster shots

Certain infectious diseases, such as COVID or the flu, evolve constantly, shapeshifting just enough to outmaneuver our immune systems and reinfect us repeatedly. But subsequent reinfections often don't lead to the most severe ...

Cardiology

New cardiovascular disease risk marker discovered in older women

Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heart ...

Immunology

Cause of inflammatory bowel disease discovered

Chronic inflammatory bowel disease (IBD) is becoming increasingly widespread. Until now, however, the underlying causes of the inflammation responses were unclear. Scientists at the Technical University of Munich (TUM) have ...

Diseases, Conditions, Syndromes

Minimizing long-term lung damage in COVID patients

A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae—chronic complications resulting from COVID-19 infection, according to a review published this ...

Diseases, Conditions, Syndromes

How omicron escapes from antibodies

A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.

Immunology

'Boot camp' enzyme prevents autoimmune conditions

WEHI researchers have identified an enzyme in the thymus that is essential for immune T cells to correctly identify threats, safeguarding them from going rogue and attacking healthy tissue in the body.

Diseases, Conditions, Syndromes

Researchers develop molecular traps to target SARS-CoV-2

A research team led by scientists at UC Riverside and UCLA has engineered novel nanoparticles to serve as "molecular traps" to target SARS-CoV-2, the virus that spreads COVID-19. The traps bind to SARS-CoV-2 and prevent it ...

Diseases, Conditions, Syndromes

Opinion: Could probiotics help fight off COVID-19?

You've probably heard of probiotics—the "good bacteria" that can benefit our health. We consume them in an expanding variety of ways, often in foods marketed as being healthy. These bacteria can be contained in supplement ...

Oncology & Cancer

Researchers discover how lactic acid weakens anti-tumor defenses

In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our defense against tumors. Until now, however, we did not know exactly ...

Immunology

Impaired neutrophils in autoimmunity

Patients with autoimmune diseases such as systemic lupus erythematosus (SLE) have higher blood levels of the protein S100A9, but the source of this protein has not been identified.

Diseases, Conditions, Syndromes

A possible tool for predicting who will experience long COVID

A team of researchers from University Hospital Zurich, the University of Zurich, Uster Hospital, Limmattal Hospital and City Hospital, all in Switzerland, has developed a tool that could possibly predict which patients infected ...

Immunology

Scientists discover new avian immunological pathway

A research team led by a biomedical scientist at the University of California, Riverside, has discovered a new immune pathway in chickens that viruses—such as those that tend to infect birds, humans, and animals and spread ...